Clinical Trials List
2021-10-01 - 2025-12-30
Phase III
Recruiting3
ICD-10C64.1
Malignant neoplasm of right kidney, except renal pelvis
ICD-10C64.2
Malignant neoplasm of left kidney, except renal pelvis
ICD-10C64.9
Malignant neoplasm of unspecified kidney, except renal pelvis
ICD-10C7A.093
Malignant carcinoid tumor of the kidney
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9189.0
Malignant neoplasm of kidney, except pelvis
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
200 participants
